TUMOR NECROSIS FACTOR INHIBITORS

You have access
Incidence of Malignancies in a Cohort of Psoriatic Arthritis Patients Taking Traditional Disease Modifying Antirheumatic Drug and Tumor Necrosis Factor Inhibitor Therapy: An Observational Study
Luisa Costa, Francesco Caso, Antonio Del Puente, Matteo Nicola Dario Di Minno, Rosario Peluso and Raffaele Scarpa

The Journal of Rheumatology December 1 2016, 43 (12) 2149-2154; DOI: https://doi.org/10.3899/jrheum.160542
You have access
Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden
Johan K. Wallman, Jonas K. Eriksson, Jan-Åke Nilsson, Tor Olofsson, Lars-Erik Kristensen, Martin Neovius and Pierre Geborek

The Journal of Rheumatology July 1 2016, 43 (7) 1292-1299; DOI: https://doi.org/10.3899/jrheum.150617
You have access
Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis
Fabiola Atzeni, Luisa Costa, Francesco Caso, Raffaele Scarpa and Piercarlo Sarzi-Puttini

The Journal of Rheumatology Supplement November 1 2015, 93 79-81; DOI: https://doi.org/10.3899/jrheum.150643
You have access
Single-joint Assessment for the Evaluation of Intraarticular Treatment: Responsiveness and Discrimination of the Composite Change Index
Caroline J. Aalbers, Danielle M. Gerlag, Margriet J. Vervoordeldonk, Paul P. Tak and Robert B. Landewé

The Journal of Rheumatology September 1 2015, 42 (9) 1672-1676; DOI: https://doi.org/10.3899/jrheum.140956
You have access
Treatment with Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Comparison Between Private Rheumatology Practices and Academic Centers in a Large Observational Cohort
Adrian Ciurea, Ulrich Weber, Daniel Stekhoven, Almut Scherer, Giorgio Tamborrini, Jürg Bernhard, Martin Toniolo, Peter M. Villiger, Pascal Zufferey, Rudolf O. Kissling, Beat A. Michel and Pascale Exer on behalf of the Rheumatologists of Swiss Clinical Quality Management

The Journal of Rheumatology January 1 2015, 42 (1) 101-105; DOI: https://doi.org/10.3899/jrheum.140229
You have access
Drug Therapies for Peripheral Joint Disease in Psoriatic Arthritis: A Systematic Review
Maria Laura Acosta Felquer, Laura C. Coates, Enrique R. Soriano, Roberto Ranza, Luis R. Espinoza, Philip S. Helliwell, Oliver FitzGerald, Neil McHugh, Euthalia Roussou and Philip J. Mease

The Journal of Rheumatology November 1 2014, 41 (11) 2277-2285; DOI: https://doi.org/10.3899/jrheum.140876
You have access
Recent Trends in Medication Usage for the Treatment of Juvenile Idiopathic Arthritis and the Influence of Tumor Necrosis Factor Inhibitors
Melissa L. Mannion, Fenglong Xie, Jeffrey R. Curtis and Timothy Beukelman

The Journal of Rheumatology October 1 2014, 41 (10) 2078-2084; DOI: https://doi.org/10.3899/jrheum.140012
You have access
Determinants Associated with Work Participation in Patients with Established Rheumatoid Arthritis Taking Tumor Necrosis Factor Inhibitors
Sofie H.M. Manders, Wietske Kievit, Annemarie L.M.A. Braakman-Jansen, Herman L.M. Brus, Lidy Hendriks, Jaap Fransen, Mart A.F.J. van de Laar and Piet L.C.M. van Riel

The Journal of Rheumatology July 1 2014, 41 (7) 1263-1269; DOI: https://doi.org/10.3899/jrheum.130878
Open Access
Clinical, Functional, and Radiographic Implications of Time to Treatment Response in Patients With Early Rheumatoid Arthritis: a Posthoc Analysis of the PREMIER Study
Edward C. Keystone, Boulos Haraoui, Benoît Guérette, Neelufar Mozaffarian, Shufang Liu and Arthur Kavanaugh

The Journal of Rheumatology February 1 2014, 41 (2) 235-243; DOI: https://doi.org/10.3899/jrheum.121468
You have access
Cardiovascular Comorbidities of Psoriasis and Psoriatic Arthritis: A Report from the GRAPPA 2012 Annual Meeting
April W. Armstrong, Joel M. Gelfand, Wolf-Henning Boehncke and Ehrin J. Armstrong

The Journal of Rheumatology August 1 2013, 40 (8) 1434-1437; DOI: https://doi.org/10.3899/jrheum.130457

Main menu

User menu

Search

TUMOR NECROSIS FACTOR INHIBITORS

Pages

Content

Resources

Subscribers

More